GO:0070522 ERCC4-ERCC1 complex: Components, Assembly and Research Methods

The ERCC4-ERCC1 complex (GO:0070522) is a heterodimeric, structure-specific endonuclease that plays a central role in nucleotide excision repair (NER) and other DNA repair pathways. This complex is conserved across eukaryotes, with orthologs known as Rad1-Rad10 in Saccharomyces cerevisiae and XPF-ERCC1 in mammals. Its ability to cleave bubble structures and splayed-arm DNA intermediates makes it indispensable for removing bulky DNA lesions and for processing recombination intermediates. Researchers studying genome stability, cancer biology, and aging are increasingly focused on this complex because its dysfunction leads to severe human disorders. Understanding the ERCC4-ERCC1 complex at the molecular, cellular, and organismal levels is therefore essential for both basic and translational research.

The ERCC4-ERCC1 complex is a heterodimeric nucleotide-excision repair complex that possesses endonuclease activity specific for bubble structures characteristic of certain DNA lesions. It consists of two subunits: XPF/ERCC4 and ERCC1 in mammals, and Rad1p and Rad10p in S. cerevisiae. This complex functions as a structure-specific endonuclease that nicks DNA at the junction between single-stranded and double-stranded regions, thereby facilitating the removal of damaged DNA segments during NER and other repair processes.

The ERCC4-ERCC1 complex is critical for maintaining genome integrity because it executes the final incision step in nucleotide excision repair, a pathway that removes a wide variety of DNA lesions including UV-induced photoproducts and bulky chemical adducts. Beyond NER, the complex participates in homologous recombination and interstrand crosslink repair, highlighting its broad role in DNA damage response. Mutations in ERCC4 or ERCC1 cause rare autosomal recessive disorders such as xeroderma pigmentosum, Cockayne syndrome, and Fanconi anemia-like syndromes, which are characterized by extreme sensitivity to DNA-damaging agents, developmental abnormalities, and cancer predisposition. Moreover, altered expression of ERCC4-ERCC1 has been implicated in cancer chemoresistance, making it a potential therapeutic target.

The ERCC4-ERCC1 complex comprises two core subunits and interacts with numerous accessory proteins that regulate its activity and recruitment.

The activity of the ERCC4-ERCC1 complex is regulated at multiple levels. Its expression can be induced by DNA damage, and its localization to repair sites is controlled by interactions with scaffold proteins such as SLX4. Post-translational modifications, including phosphorylation and ubiquitination, modulate its stability and function. Additionally, the complex is regulated by cell cycle-dependent factors, ensuring that incision occurs at appropriate times.

Mutations in ERCC4 or ERCC1 cause rare autosomal recessive disorders characterized by extreme sensitivity to UV light, developmental abnormalities, and predisposition to skin cancer. These conditions highlight the critical role of the ERCC4-ERCC1 complex in nucleotide excision repair and genome maintenance.

The ERCC4-ERCC1 complex is essential for interstrand crosslink repair, and its dysfunction leads to Fanconi anemia-like phenotypes, including bone marrow failure and cancer predisposition. This connection underscores the complex's role beyond NER in maintaining genomic stability.

Overexpression of ERCC4-ERCC1 has been associated with resistance to platinum-based chemotherapies in various cancers, making it a potential biomarker and therapeutic target. Inhibiting the complex could sensitize tumors to DNA-damaging agents.

Genome-wide CRISPR knockout screens can identify genes that synthetically interact with ERCC4-ERCC1, revealing new vulnerabilities in cancer cells. These screens are powerful for uncovering pathways that compensate for loss of the complex.

Affinity purification coupled with mass spectrometry (AP-MS) can identify novel interacting partners of the ERCC4-ERCC1 complex, providing insights into its regulation and functions. Proximity labeling approaches such as BioID can map the complex's interactome in living cells.

Fluorescence microscopy of tagged ERCC4 or ERCC1 can visualize the complex's recruitment to DNA damage sites in real time. This approach helps dissect the kinetics of assembly and disassembly during repair.

In vitro endonuclease assays using bubble DNA substrates can measure the catalytic activity of purified ERCC4-ERCC1 complex. These assays are essential for structure-function studies and inhibitor screening.

Researchers studying ERCC4-ERCC1 complex-related genes often need to determine whether a candidate gene is causally involved in DNA repair, cancer chemoresistance, or developmental disorders. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from generating precise knockout and knock-in cell lines to performing high-throughput screens and bioinformatics analysis.

The ERCC4-ERCC1 complex (GO:0070522) is a central player in DNA repair, with critical roles in nucleotide excision repair, homologous recombination, and interstrand crosslink repair. Its dysfunction leads to severe human diseases, and its overexpression contributes to cancer chemoresistance. Continued research using advanced CRISPR models and high-throughput methods will further illuminate its mechanisms and therapeutic potential.